Zura Bio (ZURA) Capital Expenditures (2024 - 2026)

Zura Bio's Capital Expenditures history runs 3 years deep, the most recent figure standing at $5000.0 for Q1 2026.

• On a quarterly basis, Capital Expenditures changed N/A year-over-year to $5000.0 in Q1 2026; TTM through Mar 2026 was $118000.0, a 82.92% decrease from a year earlier, with the FY2025 full-year figure at $113000.0, down 83.81% from the prior year.
• Capital Expenditures retreated to $5000.0 in Q1 2026 per ZURA's latest filing, from $17000.0 in the prior quarter.
• Across five years, Capital Expenditures topped out at $668000.0 in Q4 2024 and bottomed at $5000.0 in Q1 2026.
• The 3-year median for Capital Expenditures is $15000.0 (2024), against an average of $102000.0.
• Biggest YoY gain for Capital Expenditures was 540.0% in 2025; the steepest drop was 97.46% in 2025.
• Year by year, Capital Expenditures stood at $668000.0 in 2024, then slumped by 97.46% to $17000.0 in 2025, then tumbled by 70.59% to $5000.0 in 2026.
• Per Business Quant, the three latest ZURA Capital Expenditures figures stand at $5000.0 (Q1 2026), $17000.0 (Q4 2025), and $32000.0 (Q3 2025).